Anika Therapeutics (ANIK)
$55.42
0.12 (0.22%)
ANIK Stock Quote Delayed 15 Minutes
Previous Close
$55.54
Market Cap
793.09M
PE Ratio
43.30
EPS
1.28
Volume (Avg. Vol.)
134,772
Day's Range
54.82 - 56.81
52-Week Range
29.01 - 75.71
Dividend & Yield
N/A (N/A)
ANIK Stock Predictions, Articles, and Anika Therapeutics News
7 Health Care Equipment & Supplies Stocks to Buy Now
7 Health Care Equipment & Supplies stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
Dump Horizon Pharma PLC (HZNP) Stock Now! Don’t Wait!
Horizon Pharma is fading after ugly guidance, and the HZNP stock chart is terrible. Sell this biotech stock before its November report.
16 Health Care Equipment & Supplies Stocks to Buy Now
The grades of 16 Health Care Equipment & Supplies stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
13 Health Care Equipment & Supplies Stocks to Buy Now
The grades of 13 Health Care Equipment & Supplies stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
3 Medical Devices Stocks to Buy Now
The grades of three medical devices stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Anika Therapeutics: A Hot Small Cap Flying Under the Radar
Anika Therapeutics is a small-cap biotech company with real products, real revenues and very real earnings driving its stock price higher.
4 Biotech Stocks to Buy
If this August is like most Augusts, the overall market isn't going to perform well for the next few weeks; biotech stocks may be the only worthwhile stocks to buy
3 Healthcare Stocks to Buy Before Earnings
Healthcare is a fast-growing segment of the market -- but which healthcare stocks should you buy? Let's take a look at 3 winners before earnings.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
